Home

Cancer:

PDT Laser

A Deeper Look into the Science of Alternative Cancer Treatments
Dr. Antonio Jimenez, M.D.

In the September 2013 publication of the ACAM Voice newsletter, we wrote about the Seven Key Principles of Cancer Therapy and how they are intricately connected together in the article entitled "Alternative Cancer Treatments and the Rubik's Cube". The importance of alternative treatments as applied to chronic diseases, including cancer, cannot be over-stressed. This paper shares some of our insight into the scientific basis of these treatment paradigms, illustrated by one of our mainstay treatments,

Sono-Photo Dynamic Therapy.

Misconceptions About Complementary and Alternative Medicine (CAM)

Most people, and an astonishingly large number of medical professionals, have a nebulous concept of what alternative medicine is all about. Part of that comes from the various existing approaches to alternative medicine. In some developed countries, Germany being a great example, complementary and alternative medicine (CAM) is very well accepted. In Germany, over 75% of conventional medicine physicians prescribe CAM, while more than 2/3rds of patients report using different forms on non-conventional therapies. With over 13,000 CAM practitioners and several organizations, CAM in Germany represents a well-organized health sector that recognizes the value such medicine to patients suffering from different types of chronic disease.
This is not true for other countries. In countries where CAM is not well organized, such as the United States, the concept is often considered too good to be true, incompatible with conventional medicine, ineffective, unscientific and worse.
Especially when it relates to cancer, many patients get attracted to CAM, concerned with the possible side effects and lack of efficacy of conventional methods. But simultaneously, they voice concerns about CAM as an effective approach, a thought that is abetted by a conventional world of medicine that heavily promotes a one-sided approach to cancer therapy through media and authoritative medical professionals.

Doing what is best for our patients should really be the guiding principle of all medicine, and we hope that someday the integration of conventional and complementary approaches to cancer will usher a new world of hope for cancer patients looking for the ultimate solution to their malady.

Cancer: Multiple Mechanisms of Action and Evasion
Cancer holds a special place in the list of diseases that ail people. For sci-fi movie buffs, cancer is a lot like the aliens in the "Alien" franchise of movies – these parasitic creatures always find ways to evade and survive, ultimately resulting in the destruction of their host. Cancer is a constantly moving target, and is difficult to classify as a single disease.

Cancer affects the whole body – even in its initial stages as a localized tumor, it has repercussions throughout the body. In fact, we prefer view this concept in reverse: we consider cancer as a systemic change in the whole body environment (also called the cancer terrain), which causes cancer to find its roots in the first place.
It is therefore fitting that a whole body disease needs to be treated taking the whole body into consideration. Stabilizing the disturbed hemostasis is not secondary to cancer treatment – it is primary. That is why we focus on not just treating the symptom, but also the inducing factors that cause the symptom in the first place.

Consider the various mechanisms that are a hallmark of cancer:
1. Self-sufficiency in growth signals that result in sustained growth and multiplication of cancer cells.
2. Insensitivity to anti-growth signals, the biochemical messengers that attempt to maintain balance in cell populations.
3. Evasion of programmed cell death, a process that in the normal body ensures the death of old cells and replacements with viable healthy cells. This preserves cancer cells well past their appointed expiry date.
4. Tissue invasion and metastasis, a hallmark of cancer cells that results in their ability to adversely impact both nearby tissue and organs as well as distant ones.
5. Limitless replicative potential separates cancer cells from healthy cells. Cancer cells can multiply endlessly, making them extremely dangerous to the rest of the body fighting for space, nutrition and structural integrity.
6. Sustained angiogenesis that ensures nutrition for cancer cells through their independent network of constantly forming blood vessels.
7. Capacity to escape immune control wherein the body's guardians are rendered helpless against the invading enemy either through suppression or evasion.
Each of these mechanisms involves multiple biochemical pathways. Pharmaceutical companies create drugs that are tested in their ability to block specific mechanistic pathways. For example, mitotic inhibitors block cell replication, kinase inhibitors block different signal pathways used by cancer cells to control function and growth, hormone therapy blocks specific hormones or their ability to interact with cancer cells that get triggered by them and so on.

The three main issues here are: first, cancer always finds a way around the blocked pathway; second, the chemotherapy bears its own burden of toxicity with numerous side effects; third, the presence of cancer stem cells is ignored: these are dormant seed cells that have all the genetic information and cellular viability to recreate entire tumors, resistant to the chemotherapy insult.

A whole body approach instead looks at the various factors that affect the viability of cancer, while addressing the underlying causes in their entirety. The ability to tackle the various dimensions of cancer that closely interplay with each other is what makes alternative cancer therapies unique in their ability to affect the disease.

The Seven Key Principles of Cancer Therapy

In our recently published paper, entitled "The Seven Key Principles of Cancer Therapy: Alternative Approaches to Disease Resolution"1 we discuss seven key principles that have formed the bedrock of our approach to the treatment of cancer using non-toxic methods over the past 25 years. These are:
1. Non-Toxic Cytolytic and Cytostatic Therapies
2. Enhance & Optimize the Immune System
3. Full Spectrum Nutrition
4. Detoxification (Heavy Metals & Toxins)
5. Eliminate Microbes & Pathogens
6. Oxygenation
7. Spiritual & Emotional Integrity

Our therapies are designed to be safe to normal cells and will not harm vital, healthy organs. Patients do not report experiencing the side effects that are common to chemotherapy and radiation, and enjoy better quality of lives during and after treatment.
When deciding on a therapy to implement we look for a good balance between a strong science-based foundation and well-established track record in holistic medicine. While we have many treatments that we offer that fall within these principles, we will focus here on describing one of our key treatments: Sono-Photo Dynamic Therapy.

The Principles of Sono-Photo Dynamic Therapy

Sono-Photo Dynamic Therapy (SPDT) is really a combination of two individual therapies: Photodynamic Therapy (PDT) and Sonodynamic Therapy (SDT). Both these therapeutic methods have been extensively discussed in the scientific
literature and have a strong scientific basis. However, the combination of these therapies into a non-toxic modality and integration with other natural treatment methods have allowed us to accomplish results with this therapy have not been witnessed elsewhere.

 

In essence, our implementation of SPDT accomplishes the desired results from chemotherapy or radiation, without adding toxicity into the body, even as we balance the hemostatic needs of the body using the other principles outlined above.

Sono
Figure 1 illustrates the mechanism of Sono-Photo Dynamic Therapy (SPDT).

SPDT has the following requirements:
1. A Sensitizer. A sensitizer is a molecule that gets preferentially absorbed into cancer cells. When subjected to specific wavelengths of light and sound, the electrons in the sensitizer molecule get stimulated to an "excited" energy level causing the desired biological effect described below.

2. A Sound and Light Source. The range of wavelengths of sound and light used are specific to the sensitizer – in other words, they need to be in the range where they can cause the activation of the sensitizer. While light, by nature, is not penetrative, sound can utilize the water in the body as a carrier to transmit its frequencies deep into the body. As a result, the combination of light and sound allows us to address tumors at various depths in the body. We have also worked to enhance our light technology. Our portable, pulsed LED light source is both easy to use as well as many times more penetrative than a regular light source of the same wavelength.

3. Molecular Oxygen. Using methods such as ozone therapy, oxygen supplements, hyperbaric chambers and direct administration of oxygen, we strive to improve the cellular concentrations of oxygen, a necessary component for the generation of reactive oxygen species explained below.

How SPDT Works: The excited sensitizer stimulates the formation of reactive oxygen species (ROS) from molecular oxygen present in the cell. The impact of ROS on cancer cells is very well documented in the literature.

The ROS leads the cancer cell to its death by severely increasing the levels of oxidative stress, causing genetic and cell membrane damage. The death of the cancer cells activates the immune system that responds to the call to clean up the debris and attacking the remaining malignant cells that are finally recognized as invaders.

SPDT also blocks the formation of new blood vessels (anti-angiogenesis), the crucial conduit for cancer cell nutrition. All these pathways are described and documented extensively in the scientific literature.

Our goal here is not to thoroughly review the science of SPDT, but to provide some examples of what is already known about these therapies: The progress of PDT applications has been reviewed extensively:

According to the Roswell Park Cancer Institute, PDT using the drug Photofrin® (porfimer sodium) has been approved for various applications worldwide (in Canada, bladder and esophageal cancer; in The Netherlands, lung and esophageal cancer; in Japan, early lung cancer; in France, early and late stage lung cancer; in Germany, early lung cancer). Photofrin®-PDT has been approved by the U.S. Food & Drug Administration for the palliative treatment of advanced esophageal cancer, Barrett's esophagus with high grade dysplasia, advanced lung cancer (obstruction tumors located in the airway), and the treatment of early stage lung cancer (located in the airway) with curative intent.

Researchers have established that photodynamic therapy (PDT) generates a long-term, anti-tumor immune response elicited by phototoxic damage with an intermediate inflammatory stimulus.

The scientific basis for the anti-angiogenic effect of PDT is detailed by researchers who have shown that microvascular collapse is readily observed following PDT, and can lead to persistent post-PDT tumor hypoxia.7

While not as extensively investigated as PDT, Sonodynamic Therapy (SDT) also has sufficient precedent as a powerful anti-cancer therapy in the scientific literature. In a recent review, the authors describe the various potential mechanisms of SDT that could range from chain peroxidation of membrane lipids, the physical destabilization of the cell membrane, ultrasound induced free radicals and more.

9 Kuroki and co-authors have reviewed a number of sonosensitizers that can be used for sonodynamic therapy in a recent mini-review.

Hundreds of other scientific studies have detailed the efficacy of SDT, which will be reviewed elsewhere in future publications.


Clinical Demonstration: The Effect of Sono-Photo Dynamic Therapy on Tumor Vascularity
For the many years during which we have implemented SPDT as one of our key treatment protocols, we have accumulating clinical experience that points towards the efficacy of the protocol as a powerful treatment modality for cancer patients.
In unpublished work, we have recently evaluated the effect of SPDT on tumor vascularity. Using High Resolution Color Doppler Ultrasound technology, we routinely monitor not just the tumor size for our patients, but also the degree of
Sonodynamic therapy of cancer using novel sonosensitizers. Anticancer Research 27:3673-3677.
blood flow in the tumor that correlates to the viability of the tumor. The use of this method is increasing rapidly in cancer patients (alongside the use of contrast-enhanced MRI) for the non-invasive but accurate prognosis, therapy monitoring or prediction of therapy success. This study was conducted entirely at Hope4Cancer Institute's Baja California clinic location.
A total of 50 randomly selected patients treated at Hope4Cancer between January 2012 and June 2013 were studied. Two treatment modalities, SPDT and the BX Protocol, were evaluated as independent treatments, or in a combined protocol. The cancer and gender distribution for the study is shown in Figure 2.
Figure 2. Gender and Cancer Distribution in Vascularity Study.

Gender
The patients were monitored once before and a second time at the end of their stay at the clinic (average of 2-3 weeks). The following chart (Figure 3) shows the drastic reduction in vascularity demonstrating, in particular, the powerful effect of SPDT (Figure 3) where the average reduction of vascularity was over 53.8%.

Vascularity
Conclusion
The integration of science-based treatments into traditional natural medicine enables us to provide powerful evidence-based treatment protocols to cancer patients without inducing negative toxicity-induced side effects. As alternative cancer treatments continue to improve, we can envision a world where cancer is treated effectively using combination protocols that take into account the diversity of stimuli that affect the growth and recurrence of cancer.

References:

1 Jimenez, A.; Chakravarty, S. (2012) The seven key principles of cancer therapy: alternative approaches to disease resolution. Forum on Immunopathological Diseases and Therapeutics, 3:281-308.

5 Schumacker, P.T. (2006) Reactive oxygen species in cancer cells: Live by the sword, die by the sword. Cancer Cell 10: 175-176.
6 Huang, Z. (2005) A review of progress in clinical photodynamic therapy. Technol. Cancer Res. Treat. 4:283-293.
7 Dolmans, D.E.J.G.J.; Fukumura, D.; Jain, R. (2003) Photodynamic therapy for cancer. Nature Reviews Cancer 3: 380-387.

5 Okunaka, T.; Kato, H.; Konaka, C.; Kawate, N.; Yamamoto, H.; Ikeda, N.; Hayata, Y.; Bonaminio, A.; Tolentino, M.; Eckhauser, M.L. (1991) Photodynamic therapy for multiple primary bronchogenic carcinoma. Cancer 68:253-258.
6 Oleinick, N.L.; Agarwal, M.L.; Berger, N.A.; Cheng, M.-F.; Chatterjee, S.; He. J.; Kenney, M.E.; Larkin, H.E.; Mukhter, H.; Rihter. B.D.; Zaidi, S.I.A. Signal transduction and metabolic changes during tumor cell apoptosis following phthalocyanine-sensitized photodynamic therapy. SPIE Proceedings, Vol. 1881, 1993.
7 Henderson, B.W.; Fingar V.H. (1989) Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model. Photochemistry and Photobiology 49: 299-304.
8 Rosenthal, I.; Sostaric, J.Z. (2004) Sonodynamic therapy – a review of the synergistic effects drugs and ultrasound. Ultrasonics Sonochemistry 11:349-363.
9 Kuroki, M.; Hachimene, K.; Abe, H.; Shibaguchi, H.; Kuroki, M.; Maekawaw, S.-I.; Yanagisawa, J.; Kinugasa, T.; Tanaka, T.; Yamashita, Y. (2007).


---------------------------------------------
Dr. Antonio Jimenez, M.D. is the Founder and Medical Director of the Hope4Cancer® Institute (established 2001) located in Baja California, Mexico. As a physician with 25 years of experience treating cancer and other chronic diseases with alternative, non-toxic methods, Dr. Jimenez is known internationally for his "Seven Key Principles for Cancer Therapy" and the clinical introduction of pioneering treatment methods such as Sono-Photo Dynamic Therapy and the BX Antitoxin Protocol. Dr. Jimenez has been an active member of ACAM in good standing since 2009.

Recent success for Paul who was advised by Western Medicine to have his ear surgically removed because of this cancer.

However he chose a Russian complimentary therapy at the Smile Australia clinic.

The excellent result followed a single treatment at our clinic and two weeks of healing.

8/10/13

Paul ear cancer

21/10/13

Paul's Ear Healed

Similar results are possible with deeper organs, using different protocols, ring 0412 994 001 to make an appointment.

 

Dr Servan-Schreiber survived 20 years with a brain tumour!

Dr Servan-Schreiber provides compelling evidence and arguments for participating in your own health by supporting your deep natural capacity for healing. He speaks with a powerful voice from both personal experience with cancer at a young age and from his life's calling as a physician and neuroscientist.-

Jon Kabat-Zinn, professor of medicine emeritus, University of Massachusetts Medical School.

Dr Servan

Having been treated twice for a malignant brain tumor, Servan-Schreiber became a leading figure in his engagement for integrative approaches to the prevention and treatment of cancer. He popularized his knowledge through teaching seminars, lectures, books, a blog and audio books. He died of brain cancer in Fécamp on July 24 2011, after almost 20 years fighting cancer.

The failure of current cancer treatments:

SEER represents the results of western medicine alone in the USA: surgery, radiotherapy and chemotherapy.

Oasis in Mexico uses western medicine together with several complimentary treatments. The majority of these complementary treatments are available at the Smile Australia Clinic in Victoria, Australia. Telephone 0412 994 001 to make an appointment.

Colon

“Current strategies to control cancer are demonstrably not working.”

The Lancet: Volume 381, Issue 9865, Page 423, 9 February 2013

Feb 4 was World Cancer Day, an opportunity to critically consider progress against cancer. Is it fair to say that the cancer medical community has failed patients living with cancer? This is a harsh statement, but according to respected oncologist, Franco Cavalli, whose Comment leads a discussion about cancer in today's Lancet: “Current strategies to control cancer are demonstrably not working.”

We publish four Comments related to World Cancer Day and a Seminar on acute myeloid leukaemia in adults. Cavalli indeed gives a blunt description of the challenge we face from cancer and he appeals to world leaders and policy makers for more effective action against cancer to incorporate the Stop Cancer Now appeal, which emphasises the UN goal of reducing premature deaths from non-communicable diseases by 25% by 2025.

In October, 2012, cancer researchers, clinicians, policy makers, industry representatives, patient advocates, and journalists from several titles, including The Lancet, met in Lugano, Switzerland, at the World Oncology Forum. Their ten-point message can be paraphrased as doing what we know how to do better in terms of prevention, treatment, and care; and learning what we do not yet know more efficiently through new models of research focused on patient benefit. Central mechanisms for achieving these changes include having a clear cancer strategy for each country, universal health coverage to deliver higher quality cancer care, and to wage war on tobacco.

World Cancer Day, 2013, set out to debunk many myths about cancer. One of those myths is that cancer is solely a health issue. The Comment by Ara Darzi and colleagues debunks that myth well by presenting some socioeconomic aspects of cancer and how these relate to sustainable development. Their message is a reminder of the increasing challenge of cancer in developing countries. Felicia Knaul, Rifat Atun, Paul Farmer, and Julio Frenk elaborate on the cancer divide in their online Comment, describing how low-income and middle-income countries have only 5% of the finance to deal with 80% of the burden of cancer.

The size of the shadow cast by cancer is enormous, as shown in The Lancet's special issue on the Global Burden of Disease Study 2010 published last December. This collaboration revealed the true and surprising extent of the rapid transitions the world is seeing—demographic, disease, disability, and risk. A key finding is the epidemic nature of non-communicable disease and its attendant risk factors. Cancer is a high priority within this broad agenda. Worldwide cancer diagnoses and deaths are increasing. 8 million people died from cancer in 2010, a 38% increase compared with 1990. Cancer diagnoses are estimated to double by 2030.

Global problems have local contexts. Therefore, it was disappointing to read research by Lindsay Forbes and colleagues that a third of people in the UK aged 50 years or older would be reluctant to present symptoms that they recognise as being suggestive of cancer to their general practitioner, because of worry about wasting doctor's time. The study of differences in cancer awareness and beliefs is part of the International Cancer Benchmarking Partnership. The Partnership seeks to improve cancer care by better understanding differences in performance between Australia, Canada, Denmark, Norway, Sweden, and the UK—countries with similar wealth, access to care, and register quality—but dissimilar outcomes. Earlyresults, published in The Lancet in 2011, showed that survival for colorectal, lung, breast, and ovarian cancer was lower in the UK, particularly in the first year after diagnosis. Examples like this one show that even among people with similar demographics, understanding of cancer, and attitudes towards cancer, perceived barriers can be as important as actual barriers to care. To promote earlier and more effective engagement of patients with cancer care will require a cultural shift by health professionals, political leaders, and citizens alike, to encourage access.

So let us return to the question we began with—has cancer medicine failed patients? In the words of cancer experts, the answer is yes. But the cancer community, together with other essential parts of the health care system (eg, primary care), recognise the deficiencies of the past. They are determined to write not a new war plan but a new future for patients at risk of—or living with—cancer. 2013 must be a watershed year for cancer.

With Western Medicine admitting failure it is critical that cancer patients include complementary therapies in their treatment plan:

Telephone 0412 994 001 to make a free appointment to discuss your options.

 

Why don’t we cure more cancer patients?

Coupla


By Philip A. Salem, M.D.


The recent New York Times front page story on a study criticizing care in cancer of the ovaries is timely and relevant. This study found “that only a little more than a third of patients received the best possible care.” However, it does not recognize that this problem is not confined to the treatment of ovarian cancer but relates to all kinds of cancer.


There are two major reasons for that: The bulk of cancer patients in America do not seek experts’ opinions. Even when patients come to centers of excellence, it is becoming more difficult for them to receive the best treatment.
When I look back on my journey of 46 years in cancer medicine and research stretching from Memorial Sloan Kettering Cancer Center in New York to M.D. Anderson and to St. Luke’s Episcopal Hospital in the Texas Medical Center, I cannot but wonder: Why don’t we cure more patients?


The answer is simple. We have failed to implement the knowledge generated from research in the actual treatment of patients. There is a major gap between what is considered the best treatment and the treatment patients actually receive because of excessive government rules and insurance company barriers. In my opinion, the nation’s best product is not Coca Cola; it is American medicine.


Patients come to America from all over the world for advanced and innovative treatments. However, the government has often reduced medicine to a contractual, legal, even businesslike relationship between a “provider” and a “consumer.” I cannot think of anything more corrosive to the dignity of the sick than being considered “a consumer” or even more demeaning to the doctor to be considered “a provider.” This terminology is a spillover from the culture of corporate America. The relationship between a doctor and his patient is not about business; it is about life and the quality of that life.
Also, it is unfortunate that the nation’s health-care debate has focused on the economics of medicine rather than the essence of medicine: how to salvage life and how to heal the sick.


While few doubt the need for the health-care system in the United States to better control the cost of care, it should not be done at the expense of the quality of care of our patients. Most of those who regulate our health-care system have never been to a medical school or have never treated a patient.
As a result of government regulations, doctors are drowning in paperwork and bureaucracy, leaving them little time to tend to patients’ needs. Rather than focusing on the best patient care, doctors have to focus on protection against legal action. Instead of nurturing a strong human bond with the patient, the doctor has become apprehensive of the patient. The doctor’s ultimate role is to provide the best scientific knowledge and most humane care. This should supersede any other role.


Insurance is another obstruction to the delivery of high-quality cancer treatment and care, interfering with the decision-making process at every step: prevention, early diagnosis, diagnosis of advanced disease and treatment. There is a prevailing misconception that a patient should be treated according to “standard” protocols. The American Society of Clinical Oncology recommends that treatment should be personalized, as cancer differs significantly from one patient to another. However, doctors are reluctant to treat patients outside standard protocols and guidelines and are not free to treat patients the way they think is best, because they are forced to treat within the constraints of insurance reimbursement. For example, a PET scan that can delineate areas in the body affected by cancer — crucial information for appropriate treatment — is frequently declined by insurance.


In addition, giving appropriate dosage of chemotherapy is commonly associated with moderate to significant toxicity. Consequently, the patient must receive treatment for nausea, vomiting, fatigue and other side effects, but major components of this therapy may not be reimbursed by insurance.
Another obstacle is that doctors are not usually reimbursed for time spent when the patient is not physically present in the clinic. In cancer medicine, no therapy strategy can be designed without group consultations with surgeons, radiation therapists, pathologists, diagnostic radiologists and other specialists — such consultations are often obtained while patients are absent. When this process of consultations is jeopardized, quality of care significantly deteriorates.


In addition, and most important, cancer patients require love, compassion, understanding and hope. Knowledge alone is never enough. The patient needs to see the doctor frequently, so suffering, pain and anxiety are alleviated. In cancer the journey is long and stormy. For treatment to succeed, both patient and doctor need courage, perseverance and hope. This comprehensive approach to treatment demands time no longer available to the doctor.


To deliver highest-quality medical care and to cure more cancer patients, doctors must be liberated from the excessive restrictions of insurance and overregulation by the government. The Texas Medical Center is the largest of its kind in the world and should take the lead in this direction. Cutting health-care costs is important, but it must not reduce the quality of care.


The most important human right should be the right of the sick to receive the very best treatment. For our dignity and the dignity of the sick, we should insist that the sick deserve nothing less.


Dr. Philip Salem is in private practice at the Salem Oncology Center and served as the director of cancer research at St. Luke’s Episcopal Hospital before retiring in 2012.

 

My Top 12 Cancer Prevention Strategies: Dr Mercola

Couple

There is so much you can do to lower your risk for cancer. But please don’t wait until you get the diagnosis—you have to take preventative steps NOW. It’s much easier to prevent cancer than to treat it, once it takes hold. I believe you can virtually eliminate your risk of cancer and chronic disease, and radically improve your chances of recovering from cancer if you currently have it, by following these relatively simple strategies.

  1. Food Preparation: Eat at least one-third of your food raw. Avoid frying or charbroiling; boil, poach or steam your foods instead. Consider adding cancer-fighting whole foods, herbs, spices and supplements to your diet, such as broccoli, curcumin and resveratrol. To learn more about how these anti-angiogenetic foods fight cancer, please see our previous article: "Dramatically Effective New Natural Way to Starve Cancer and Obesity."
  2. Carbohydrates and Sugar: Reduce or eliminate processed foods, sugar/fructose and grain-based foods from your diet. This applies to whole unprocessed organic grains as well, as they tend to rapidly break down and drive up your insulin level. The evidence is quite clear that if you want to avoid cancer, or you currently have cancer, you absolutely MUST avoid all forms of sugar, especially fructose, which feeds cancer cells and promotes their growth. Make sure your total fructose intake is around 25 grams daily, including fruit.
  3. Protein and Fat: Consider reducing your protein levels to one gram per kilogram of lean body weight. It would be unusual for most adults to need more than 100 grams of protein and most likely close to half of that amount. Replace excess protein with high-quality fats, such as organic eggs from pastured hens, high-quality meats, avocados, and coconut oil.
  4. GMOs: Avoid genetically engineered foods as they are typically treated with herbicides such as Roundup (glyphosate), and likely to be carcinogenic. A French research team that has extensively studied Roundup concluded it’s toxic to human cells, and likely carcinogenic to humans. Choose fresh, organic, preferably locally grown foods.
  5. Animal-Based Omega-3 fats: Normalize your ratio of omega-3 to omega-6 fats by taking a high-quality krill oil and reducing your intake of processed vegetable oils.
  6. Natural Probiotics: Optimizing your gut flora will reduce inflammation and strengthen your immune response. Researchers have found a microbe-dependent mechanism through which some cancers mount an inflammatory response that fuels their development and growth. They suggest that inhibiting inflammatory cytokines might slow cancer progression and improve the response to chemotherapy.
  7. Adding naturally fermented food to your daily diet is an easy way to prevent cancer or speed recovery. You can always add a high-quality probiotic supplement as well, but naturally fermented foods are the best.

  8. Exercise: Exercise lowers insulin levels, which creates a low sugar environment that discourages the growth and spread of cancer cells. In a three-month study, exercise was found to alter immune cells into a more potent disease-fighting form in cancer survivors who had just completed chemotherapy.
  9. Researchers and cancer organizations increasingly recommend making regular exercise a priority in order to reduce your risk of cancer, and help improve cancer outcomes. Research has also found evidence suggesting exercise can help trigger apoptosis (programmed cell death) in cancer cells. Ideally, your exercise program should include balance, strength, flexibility, high intensity interval training (HIIT). For help getting started, refer to my Peak Fitness Program.

  10. Vitamin D: There is scientific evidence you can decrease your risk of cancer by more than half simply by optimizing your vitamin D levels with appropriate sun exposure. Your serum level should hold steady at 50-70 ng/ml, but if you are being treated for cancer, it should be closer to 80-90 ng/ml for optimal benefit.
  11. If you take oral vitamin D and have cancer, it would be very prudent to monitor your vitamin D blood levels regularly, as well as supplementing your vitamin K2, as K2 deficiency is actually what produces the symptoms of vitamin D toxicity. To learn more, please see my previous article: "What You Need to Know About Vitamin K2, D and Calcium".

  12. Sleep: Make sure you are getting enough restorative sleep. Poor sleep can interfere with your melatonin production, which is associated with an increased risk of insulin resistance and weight gain, both of which contribute to cancer’s virility.
  13. Exposure to Toxins: Reduce your exposure to environmental toxins like pesticides, herbicides, household chemical cleaners, synthetic air fresheners and toxic cosmetics.
  14. Exposure to Radiation: Limit your exposure and protect yourself from radiation produced by cell phones, towers, base stations, and Wi-Fi stations, as well as minimizing your exposure from radiation-based medical scans, including dental x-rays, CT scans, and mammograms.
  15. Stress Management: Stress from all causes is a major contributor to disease. Even the CDC states that 85 percent of disease is driven by emotional factors. It is likely that stress and unresolved emotional issues may be more important than the physical ones, so make sure this is addressed. My favorite tool for resolving emotional challenges is Emotional Freedom Techniques (EFT).

Telephone 0412 994 001 to make a free consultation.

 

 

 

Return: